HighVista Strategies LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$612,000
-58.7%
12,108
-12.5%
0.37%
-68.8%
Q4 2021$1,483,000
+13.5%
13,843
+8.9%
1.18%
+36.5%
Q3 2021$1,307,000
+68.9%
12,716
+44.4%
0.86%
+57.6%
Q2 2021$774,000
+83.8%
8,805
+63.2%
0.55%
+57.3%
Q2 2020$421,0005,3960.35%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders